PL1778709T3 - Polisiarczany glikozydów i ich sole - Google Patents
Polisiarczany glikozydów i ich soleInfo
- Publication number
- PL1778709T3 PL1778709T3 PL05783149T PL05783149T PL1778709T3 PL 1778709 T3 PL1778709 T3 PL 1778709T3 PL 05783149 T PL05783149 T PL 05783149T PL 05783149 T PL05783149 T PL 05783149T PL 1778709 T3 PL1778709 T3 PL 1778709T3
- Authority
- PL
- Poland
- Prior art keywords
- salts
- polysulfated glycosides
- polysulfated
- glycosides
- asthma
- Prior art date
Links
- 229930182470 glycoside Natural products 0.000 title abstract 2
- 150000002338 glycosides Chemical class 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 208000006673 asthma Diseases 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59914804P | 2004-08-05 | 2004-08-05 | |
| EP05783149A EP1778709B1 (en) | 2004-08-05 | 2005-08-05 | Polysulfated glycosides and salts thereof |
| PCT/US2005/027877 WO2006017726A2 (en) | 2004-08-05 | 2005-08-05 | Polysulfated glycosides and salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1778709T3 true PL1778709T3 (pl) | 2008-10-31 |
Family
ID=35781354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05783149T PL1778709T3 (pl) | 2004-08-05 | 2005-08-05 | Polisiarczany glikozydów i ich sole |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7902158B2 (pl) |
| EP (1) | EP1778709B1 (pl) |
| JP (1) | JP5164572B2 (pl) |
| KR (1) | KR101097702B1 (pl) |
| CN (1) | CN101014607B (pl) |
| AT (1) | ATE397006T1 (pl) |
| AU (1) | AU2005271349B2 (pl) |
| BR (1) | BRPI0513095A (pl) |
| CA (1) | CA2576131C (pl) |
| CY (1) | CY1108900T1 (pl) |
| DE (1) | DE602005007244D1 (pl) |
| DK (1) | DK1778709T3 (pl) |
| ES (1) | ES2308536T3 (pl) |
| IL (1) | IL181095A (pl) |
| MX (1) | MX2007001444A (pl) |
| NO (1) | NO20070987L (pl) |
| NZ (1) | NZ553292A (pl) |
| PL (1) | PL1778709T3 (pl) |
| PT (1) | PT1778709E (pl) |
| RU (1) | RU2413734C2 (pl) |
| SI (1) | SI1778709T1 (pl) |
| UA (1) | UA87154C2 (pl) |
| WO (1) | WO2006017726A2 (pl) |
| ZA (1) | ZA200700758B (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1778709T3 (pl) | 2004-08-05 | 2008-10-31 | Ivax Drug Res Institute Ltd | Polisiarczany glikozydów i ich sole |
| WO2010037180A1 (en) * | 2008-10-03 | 2010-04-08 | Glycan Biosciences Pty Ltd | Anionic oligosaccharide conjugates |
| US8993536B2 (en) * | 2009-02-02 | 2015-03-31 | Otsuka Chemical Co., Ltd. | Low-molecular polysulfated hyaluronic acid derivative and medicine containing same |
| NZ598922A (en) * | 2009-08-31 | 2014-03-28 | Depomed Inc | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| EP2506711B1 (en) | 2009-12-03 | 2019-04-03 | OPKO Health, Inc. | Hypersulfated disaccharide formulations |
| EP2632259A4 (en) * | 2010-10-29 | 2015-04-29 | Opko Health Inc | HYPERSULATED DISACCHARIDES FOR THE TREATMENT OF ELASTASE-MEDIATED DISEASES |
| WO2012058719A1 (en) * | 2010-11-02 | 2012-05-10 | The Universtity Of Sydney | Inhalable compositions |
| PT3274347T (pt) * | 2015-03-26 | 2020-10-01 | Giuliani Spa | Compostos tendo atividade antioxidante contra radicais livres e atividade anti-inflamatória, e correspondentes composições farmacêuticas para o cuidado da pele |
| TW201815394A (zh) | 2016-08-16 | 2018-05-01 | 美商歐科製藥有限公司 | 具有改良口服生物可利用性之純七硫酸化雙醣 |
| JP6225321B1 (ja) | 2016-08-31 | 2017-11-08 | 王子ホールディングス株式会社 | ポリ硫酸ペントサンの製造方法 |
| CN111148749A (zh) | 2016-08-31 | 2020-05-12 | 王子控股株式会社 | 酸性低聚木糖的生产方法和酸性低聚木糖 |
| JP6281659B1 (ja) | 2017-02-28 | 2018-02-21 | 王子ホールディングス株式会社 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
| BR112019025030A2 (pt) | 2017-05-31 | 2020-06-16 | Oji Holdings Corporation | Preparação umidificante tópica. |
| CA3075485C (en) | 2017-09-12 | 2025-07-08 | Oji Holdings Corporation | PENTOSANE POLYSULFATE AND PROCESS FOR THE PRODUCTION OF PENTOSANE POLYSULFATE |
| MX2020006605A (es) | 2017-12-20 | 2020-09-10 | Oji Holdings Corp | Polisulfato de pentosano y medicamento que contiene polisulfato de pentosano. |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2520173C3 (de) * | 1975-05-06 | 1989-08-10 | Südzucker AG Mannheim/Ochsenfurt, 6800 Mannheim | Verfahren zur Herstellung von Glucopyranosido-1,6-mannit sowie seine Verwendung als Zuckeraustauschstoff |
| US4021544A (en) * | 1976-07-12 | 1977-05-03 | American Cyanamid Company | Complement inhibitors |
| DE3734815A1 (de) * | 1987-10-14 | 1989-04-27 | Luitpold Werk Chem Pharm | Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel |
| DK505488D0 (da) * | 1987-12-21 | 1988-09-09 | Bar Shalom Daniel | Middel og anvendelse af samme |
| US5380716A (en) | 1988-12-15 | 1995-01-10 | Glycomed, Inc. | Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
| IL102758A (en) | 1991-08-23 | 1997-03-18 | Akzo Nv | Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them |
| JPH05164572A (ja) | 1991-12-12 | 1993-06-29 | Y E Data Inc | エンコーダ |
| JP3009731B2 (ja) | 1992-06-01 | 2000-02-14 | ザ バイオメンブレイン インスティテュート | オリゴ糖の還元性末端からの単糖の順次の除去およびそれらの使用 |
| DE4408248A1 (de) * | 1994-03-11 | 1995-09-14 | Hoechst Ag | Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung |
| US5783568A (en) * | 1994-06-10 | 1998-07-21 | Sugen, Inc. | Methods for treating cancer and other cell proliferative diseases |
| JPH08109134A (ja) * | 1994-10-11 | 1996-04-30 | Sanwa Kagaku Kenkyusho Co Ltd | 細胞変成抑制並びに臓器毒性軽減剤 |
| US6153736A (en) * | 1995-09-27 | 2000-11-28 | The Liposome Company, Inc. | Modified ether glyceroglycolipids |
| JPH09183789A (ja) | 1995-10-31 | 1997-07-15 | Sanwa Kagaku Kenkyusho Co Ltd | 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途 |
| IL120722A (en) * | 1996-05-08 | 1999-07-14 | Akzo Nobel Nv | Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them |
| AU5706699A (en) * | 1998-11-24 | 2000-06-13 | American Home Products Corporation | Benzyllactobionamides as inhibitors of smooth muscle cell proliferation |
| JP4913272B2 (ja) | 1999-01-07 | 2012-04-11 | 生化学工業株式会社 | オリゴ糖の製造方法ならびに新規オリゴ糖およびそれを含む医薬組成物 |
| US7056898B2 (en) * | 2001-04-16 | 2006-06-06 | Baker Norton Pharmaceuticals, Inc. | Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| JP2005531611A (ja) * | 2002-06-07 | 2005-10-20 | ズートツッカー アクチェンゲゼルシャフト マンハイム／オクセンフルト | ガラクトシル・イソマルト、その製造方法及び使用 |
| PL1778709T3 (pl) | 2004-08-05 | 2008-10-31 | Ivax Drug Res Institute Ltd | Polisiarczany glikozydów i ich sole |
| US8777575B2 (en) | 2008-10-16 | 2014-07-15 | Rolls-Royce Aktiebolag | Method and arrangement for propeller pitch control |
-
2005
- 2005-08-05 PL PL05783149T patent/PL1778709T3/pl unknown
- 2005-08-05 US US11/659,406 patent/US7902158B2/en not_active Expired - Fee Related
- 2005-08-05 KR KR1020077004162A patent/KR101097702B1/ko not_active Expired - Fee Related
- 2005-08-05 UA UAA200702270A patent/UA87154C2/uk unknown
- 2005-08-05 SI SI200530375T patent/SI1778709T1/sl unknown
- 2005-08-05 CN CN200580029844.8A patent/CN101014607B/zh not_active Expired - Fee Related
- 2005-08-05 ES ES05783149T patent/ES2308536T3/es not_active Expired - Lifetime
- 2005-08-05 EP EP05783149A patent/EP1778709B1/en not_active Expired - Lifetime
- 2005-08-05 ZA ZA200700758A patent/ZA200700758B/xx unknown
- 2005-08-05 AU AU2005271349A patent/AU2005271349B2/en not_active Ceased
- 2005-08-05 DK DK05783149T patent/DK1778709T3/da active
- 2005-08-05 PT PT05783149T patent/PT1778709E/pt unknown
- 2005-08-05 NZ NZ553292A patent/NZ553292A/en not_active IP Right Cessation
- 2005-08-05 MX MX2007001444A patent/MX2007001444A/es active IP Right Grant
- 2005-08-05 CA CA2576131A patent/CA2576131C/en not_active Expired - Fee Related
- 2005-08-05 AT AT05783149T patent/ATE397006T1/de active
- 2005-08-05 BR BRPI0513095-6A patent/BRPI0513095A/pt not_active IP Right Cessation
- 2005-08-05 RU RU2007107935/04A patent/RU2413734C2/ru not_active IP Right Cessation
- 2005-08-05 DE DE602005007244T patent/DE602005007244D1/de not_active Expired - Lifetime
- 2005-08-05 JP JP2007525025A patent/JP5164572B2/ja not_active Expired - Fee Related
- 2005-08-05 WO PCT/US2005/027877 patent/WO2006017726A2/en not_active Ceased
-
2007
- 2007-02-01 IL IL181095A patent/IL181095A/en not_active IP Right Cessation
- 2007-02-20 NO NO20070987A patent/NO20070987L/no not_active Application Discontinuation
-
2008
- 2008-08-25 CY CY20081100899T patent/CY1108900T1/el unknown
-
2011
- 2011-01-25 US US13/013,153 patent/US8987216B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL181095A0 (en) | Polysulfated glycosides and salts thereof | |
| NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| IL187005A0 (en) | Diacylglycerol acyltransferase inhibitors | |
| MX2012000488A (es) | Terapia de combinacion para el tratamiento de la diabetes. | |
| WO2008042688A3 (en) | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 | |
| WO2001081310A8 (en) | 1-aroyl-piperidinyl benzamidines | |
| GB0625648D0 (en) | Compounds | |
| WO2007143607A3 (en) | Method of treating atrophic vaginitis | |
| MY139577A (en) | Anti-inflammatory androstane derivative | |
| WO2007005668A3 (en) | Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer | |
| WO2007082068A3 (en) | Methods and compositions for treating asthma in human and non human primates | |
| KR102647942B1 (ko) | 섬유증 치료제 | |
| DK1296972T3 (da) | Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer | |
| WO2007136741A3 (en) | N-desmethyl-doxepin and methods of using the same to treat sleep disorders | |
| WO2004082590A3 (en) | A low dose corticosteroid composition | |
| JP2007501270A5 (pl) | ||
| WO2005023792A3 (en) | Macrocyclic compounds useful as pharmaceuticals | |
| WO2006017752A8 (en) | Sulfated oligosaccharides | |
| WO2005112914A3 (en) | Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease | |
| WO2006017727A3 (en) | Glycosides and salts thereof | |
| WO2007115020A3 (en) | Therapeutic prostaglandin compounds for the treatment of glaucoma | |
| MXPA05008236A (es) | Derivados novedosos de 2,3-benzodiazepina substituidos. | |
| NO20084399L (no) | Substituerte 1-amino-4-fenyl-dihydroisokinoliner, fremgangsmate for fremstilling derav, anvendelse derav som et medikament, og medikamenter inneholdende dem | |
| IS2576B (is) | Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról | |
| WO2004069195A3 (en) | Methods and compositions for treating inflammatory disorders of the airways |